FEATURED ARTICLES
How Should Scientific Focus Change In 2026? Researchers Weigh In
To kick off 2026, clinical researchers share how they think research should change in the new year.
-
![FAQs business-GettyImages-1349998432]( "FDA Further Expands And Clarifies Expanded Access FAQs")
FDA Further Expands And Clarifies Expanded Access FAQsHealthcare attorney Dianne J. Bourque breaks down the FDA's October 2025 update to its Expanded Access FAQs.
-
![Lose win-GettyImages-2211235058]( "What Is Win Ratio, And How Can It Be Used In Rare Disease Research?")
What Is Win Ratio, And How Can It Be Used In Rare Disease Research?Amber Salzman, CEO of Epicrispr Biotechnologies, explains how applying the win ratio in facioscapulohumeral muscular dystrophy (FSHD) could transform the way researchers evaluate therapeutic impact, enhance statistical efficiency, and improve trial design.
-
![lab technician working in pathology laboratory-GettyImages-1967884465]( "Adaptive Trial Design Is Changing Oncology And Hematology Clinical Trials")
Adaptive Trial Design Is Changing Oncology And Hematology Clinical TrialsPfizer Global Development Lead, Clinical Development Oncology & Hematology, Shreya Badhrinarayanan, MD, explains how adaptive trials, enriched by AI and better data integration, are transforming oncology and hematology clinical research.
SERVICES & PRODUCTS
At Endpoint Clinical, our solutions proactively problem-solve. We expect the unexpected, so you can focus on reaching key clinical trial milestones.
Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC Services
Fast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
Our dermatology studies provide results that are more than skin deep. Because the skin is the largest and most easily accessible organ, our dermatology research also facilitates drug development in other areas, including immunology and endocrinology. In addition, we are engaged in studying ways to improve wound healing.
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.